Welcome to Ligand Pharmaceuticals

Ligand is a high-growth company with economic rights to some of the world's most important medicines.

Portfolio
Technologies
Licensing Opportunities

Latest News

Ligand Provides a Corporate Update and Announces May 6th as the Date for First Quarter Earnings Call

Read More

Ligand Completes Acquisition of Icagen Core Assets, Partnered Programs and Ion Channel Technologies

Read More

Ligand’s Presentation at the Barclays Global Healthcare Conference Now a Webcast Only, New Slides Available on Ligand.com

Read More

Recent Events

Stock Snapshot

LGND
Nasdaq
Volume
Market Cap
Day Range
52-Week Range